[1]Wu J, He J, Liu Z, Zhu X, Li Z, Chen A, Lu J. Cuproptosis: Mechanism, role, and advances in urological malignancies. Med Res Rev. 2024 Jul;44(4):1662-1682. (IF=13.3, Q1, 共同通讯作者)
[2]Ji J, Xu R, Ding K, Bao G, Zhang X, Huang B, Wang X, Martinez A, Wang X, Li G, Miletic H, Thorsen F, Bjerkvig R, Xiang L, Han B, Chen A, Li X, Wang J. Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-κB Signaling. Clin Cancer Res. 2019 Nov 15;25(22):6868-6881. (IF=11.5, Q1, 共同通讯作者)
[3]Wang X, Han M, Wang S, Sun Y, Zhao W, Xue Z, Liang X, Huang B, Li G, Chen A, Li X, Wang J. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention. Theranostics. 2022 Jul 11;12(12):5451-5469.(IF=12.4, Q1, 共同通讯作者)
[4]Zhao F, Yao Z, Li Y, Zhao W, Sun Y, Yang X, Zhao Z, Huang B, Wang J, Li X, Chen A. Targeting the molecular chaperone CCT2 inhibits GBM progression by influencing KRAS stability. Cancer Lett. 2024 May 28;590:216844.(IF=9.7, Q1, 共同通讯作者)
[5]Zhao W, Wang J, Zhao F, Li Y, Li Z, Li X, Chen A. SUMOylation modification of HNRNPK at the K422 site promotes invasion in glioblastoma. Int J Biol Sci. 2024 Oct 21;20(14):5715-5730.(IF=8.2, Q1, 共同通讯作者)
[6]Li Y, Liu X, Zhao F, Zhao Z, Li X, Wang J, Huang B, Chen A. Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma. CNS Neurosci Ther. 2024 Feb;30(2):e14366.(IF=5.5, Q1, 共同通讯作者)
[7]Zhang X, Yao Z, Xue Z, Wang S, Liu X, Hu Y, Zhang Y, Wang J, Li X, Chen A. Resibufogenin Targets the ATP1A1 Signaling Cascade to Induce G2/M Phase Arrest and Inhibit Invasion in Glioma. Front Pharmacol. 2022 May 17;13:855626.(IF=5.9, Q1, 共同通讯作者)
[8]Chen A, Zhao W, Li X, Sun G, Ma Z, Peng L, Shi Z, Li X, Yan J. Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme. Front Immunol. 2022 Apr 6;13:840785.(IF=7.3, Q1, 共同通讯作者)
[9]Chen A, An Z. Editorial: The advances in proteomics and targeted therapy of malignant brain tumours. Front Oncol. 2023 Apr 25;13:1195847.(Q2, 通讯作者和第一作者)
[10]Ji J, Ding K, Luo T, Zhang X, Chen A, Zhang D, Li G, Thorsen F, Huang B, Li X, Wang J. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα. Cell Death Differ. 2021 Jan;28(1):367-381.(Q1,IF=13.7)